Baxter International Inc. Stock Borsa Italiana

Equities

4BAX

US0718131099

Medical Equipment, Supplies & Distribution

End-of-day quote Borsa Italiana 06:00:00 2024-06-05 pm EDT 5-day change 1st Jan Change
30.64 EUR +0.74% Intraday chart for Baxter International Inc. -1.73% -12.47%
Sales 2024 * 15.11B 14B Sales 2025 * 15.66B 14.5B Capitalization 16.9B 15.65B
Net income 2024 * 703M 651M Net income 2025 * 950M 880M EV / Sales 2024 * 1.77 x
Net Debt 2024 * 9.85B 9.12B Net Debt 2025 * 9.06B 8.38B EV / Sales 2025 * 1.66 x
P/E ratio 2024 *
18 x
P/E ratio 2025 *
14.8 x
Employees 60,000
Yield 2024 *
3.6%
Yield 2025 *
3.74%
Free-Float 74.27%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.74%
1 week-1.73%
Current month-1.73%
1 month-9.38%
3 months-22.93%
6 months-8.28%
Current year-12.47%
More quotes
1 week
30.41
Extreme 30.41
31.46
1 month
30.41
Extreme 30.41
33.14
Current year
30.41
Extreme 30.41
40.05
1 year
30.00
Extreme 30
44.05
3 years
30.00
Extreme 30
78.14
5 years
30.00
Extreme 30
86.73
10 years
30.00
Extreme 30
86.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 15-09-30
Director of Finance/CFO 54 23-10-17
Chief Tech/Sci/R&D Officer - 16-12-31
Members of the board TitleAgeSince
Director/Board Member 73 17-02-05
Director/Board Member 64 22-05-09
Director/Board Member 64 19-02-17
More insiders
Date Price Change
24-06-07 30.88 +0.78%
24-06-06 30.64 +0.74%
24-06-05 30.41 -2.30%
24-06-04 31.12 -1.06%
24-06-03 31.46 +0.91%

End-of-day quote Borsa Italiana, June 05, 2024

More quotes
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
33.16 USD
Average target price
45.44 USD
Spread / Average Target
+37.03%
Consensus